insights_auto
Why is GOVX down 3.32%?
Dive Deeperchevron_right
GOVX:NASDAQ
Geovax Labs Inc
$0.16
arrow_downward
-3.32%(-0.0056) 1D
$0.18
arrow_upward
+10.43% (+0.017)todayPre-market
Closed: Nov 2, 4:00:02 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GOVX...
Open
$0.18
High
$0.18
Low
$0.16
Mkt. cap
1.47M
Avg. vol.
684.67K
Volume
706.00
52-wk high
$14.35
52-wk low
$0.16
EPS
-$13.92
Beta
3.69
Shares outstanding
10.10M
No. of employees
19
Open
$0.18
High
$0.18
Low
$0.16
Mkt. cap
1.47M
Avg. vol.
684.67K
Volume
706.00
52-wk high
$14.35
52-wk low
$0.16
EPS
-$13.92
Beta
3.69
Shares outstanding
10.10M
No. of employees
19
News stories
From web sources and news partners
Tech Times
·
3 minutes ago
Broadridge Joins NYSE Tokenized Platform, Bringing Proxy Voting On-Chain
MarketWatch
·
18 minutes ago
This signal from the corporate bond market has historically preceded big drawdowns for the S&P 500
Investing.com
·
29 minutes ago
Nasdaq sank -5.3%, but these AI strategies surged up to +9.3% in October
The Motley Fool
·
49 minutes ago
The Company Behind the New York Stock Exchange Is Now Building on Hyperliquid. Here's What It Means for Investors.
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersAtlanta, Georgia, United States
SectorBiotechnology
Websitegeovax.com